TL;DR
Turn quiet afternoons into listening time
- Thousands of audiobooks, podcasts and originals
- Listen on your phone, tablet or Echo — also offline
- Cancel anytime
A MedPage Today opinion article says March 2026 ACC and AHA guidelines give coronary artery calcium scans a central role in assessing certain adults whose need for preventive treatment is uncertain. The scan can identify calcified plaque, but the article’s $100 scan and $50,000 heart attack comparison is an argument about prevention and payment—not a Medicare coverage announcement or a guaranteed cost saving.
A March 2026 update to national American College of Cardiology and American Heart Association guidelines gives coronary artery calcium scans a central role for some adults whose need for preventive treatment remains uncertain, according to a MedPage Today opinion article published October 25. The development concerns how clinicians assess coronary disease risk; it does not establish a new Medicare payment policy.
Authors Arthur Agatston, MD, and Oren Mechanic, MD, MPH, describe a coronary artery calcium scan, or CAC scan, as a roughly 10-minute test that detects calcified plaque in the coronary arteries. They say it costs about $100 and uses a fraction of the radiation of a standard chest CT. The article says the updated guidelines recommend the scan for adults at borderline or intermediate risk when the decision to begin preventive treatment, such as a statin, is not clear.
Traditional risk calculators estimate the likelihood of a future heart attack using factors including age, sex, cholesterol, diabetes, blood pressure and smoking. The authors contrast that estimate with CAC imaging, which can show calcified atherosclerotic plaque already present. They say a score of zero may support classifying a person’s risk lower, while a score above 100 may identify people who could benefit from medication and more intensive lifestyle changes. The scan result is one part of a clinical decision, not a treatment prescription by itself.
To illustrate the distinction, the authors describe a 52-year-old patient identified by a changed name as Rob. They report that his risk calculator placed him in a low-risk category, but his CAC score was 220, which they interpret as a substantial plaque burden for his age. The authors say that finding affected their view of preventive drug treatment. This is an individual example in an opinion article, not evidence that every person with a similar profile will have the same result or need the same care.
A Scan Moves Into Prevention Decisions
The guideline change may affect conversations between clinicians and patients when conventional risk estimates leave uncertainty about whether to start preventive medication. A scan that identifies plaque can provide additional information, while a zero score may help some patients and clinicians decide against medication for the time being. Decisions still depend on a person’s medical history, preferences and clinician’s assessment.
The authors frame the issue as a gap between the cost of prevention and treatment: they contrast an approximately $100 scan with a claimed $50,000 heart attack cost. That comparison is the article’s argument for earlier prevention, not a Medicare reimbursement rate or a demonstrated saving for each scan. The commentary says patients often pay out of pocket, but supplies no Medicare coverage determination or payment data. Whether broader use would improve outcomes or lower spending depends on access, clinical decisions and follow-up care.
Popular right now
Dyson Ball Animal 3 Upright Vacuum
Breville Bambino Espresso Machine, Brushed Stainless Steel (BES450BSS)
Vitamix 5200 Professional-Grade Blender, 64 oz. Container, Black
As an affiliate, we earn on qualifying purchases.
From Risk Scores to Plaque Imaging
The authors say CAC evidence accumulated for more than three decades before the March 2026 guideline update gave the test a central place in prevention guidance. They attribute its earlier limited use partly to clinical decision tools built around population risk factors, cautious guideline processes and insurance coverage constraints. Those explanations are the authors’ account of why the scan did not become routine sooner.
The article also points to artificial intelligence that can detect coronary calcification on chest CT scans obtained for other reasons. The authors say such analysis could flag people for preventive evaluation, including patients less able to pay directly for a separate scan. They also mention developing AI methods intended to assess soft plaque. The commentary presents these tools as a potential extension of prevention; it does not provide outcome data, coverage details or evidence that they are used uniformly.
“The guidelines have finally caught up to the evidence supporting coronary artery calcium scans.”
— Arthur Agatston, MD, and Oren Mechanic, MD, MPH, in their MedPage Today opinion article
Coverage and Outcomes Remain Open
The source is an opinion article, not a Medicare announcement or a report of a new reimbursement decision. It does not establish whether Medicare covers CAC scans, what beneficiaries may pay, or whether payment rules changed with the guideline update. The $100 and $50,000 figures are not accompanied in the source material by a detailed pricing methodology, defined patient group or comparison of total costs.
The article also does not provide new clinical trial results or quantify how many heart attacks would be prevented through expanded scanning. It says most heart attacks are preventable, but gives no supporting estimate or specific time period for that claim. The guideline recommendation is limited to certain adults for whom treatment decisions remain uncertain; it should not be read as a recommendation for universal screening. The effects of wider access, AI-assisted analysis and any resulting treatment on health outcomes and health spending remain unclear from the material provided.
How Guidance Reaches Patients
The immediate development is the March 2026 ACC and AHA guideline recommendation described by the authors. The source does not name a forthcoming policy deadline, Medicare decision or implementation milestone. The practical next steps for clinicians and patients will depend on how the guidance is applied in individual care and whether insurers cover testing in relevant cases.
Further information would be needed to judge the financial case made in the article: current coverage and patient-cost data, evidence on how clinicians use scan results, and measured outcomes among people assessed with CAC. The authors also argue that AI could identify calcification on existing CT scans. Whether that approach becomes a routine part of care will depend on validation, clinical workflows, access and payment decisions that the article does not specify.
Key Questions
Did Medicare announce that it will pay for a $100 CAC scan?
No such announcement appears in the source material. The article’s headline compares the stated scan cost with a heart attack cost, but the article does not establish Medicare coverage or a payment rate.
What changed in the 2026 guidelines?
According to the authors, the March 2026 ACC and AHA guidelines gave CAC scans a central role for adults at borderline or intermediate risk when clinicians and patients remain uncertain about preventive treatment.
What does a CAC scan measure?
A CAC scan detects and measures calcified plaque in coronary arteries. The authors say it can add information about existing atherosclerosis beyond risk estimates based on factors such as cholesterol and blood pressure.
Does a score of zero mean someone cannot have a heart attack?
No. The article says a score of zero may lead clinicians to classify risk lower, but it does not say the result rules out all coronary disease or future heart attacks. Scan results should be interpreted with a qualified clinician.
Is CAC scanning recommended for everyone?
The source describes a recommendation for selected adults whose risk is borderline or intermediate and whose preventive treatment decision is uncertain. It does not describe universal screening.
Source: medpagetoday.com
